Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nose-to-brain drug delivery: Challenges and progress towards brain targeting in the treatment of neurological disorders
Meenakshi Raghav, Vaishnavi Gupta, Rajendra Awasthi, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 86, pp. 104756-104756
Closed Access | Times Cited: 18

Showing 18 citing articles:

Nano biomaterials based strategies for enhanced brain targeting in the treatment of neurodegenerative diseases: an up-to-date perspective
Dur e Nayab, Fakhar ud Din, Hussain Ali, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 27
Bacteria-based drug delivery for treating non-oncological diseases
Zhenping Cao, Yan Pang, Jun Pu, et al.
Journal of Controlled Release (2024) Vol. 366, pp. 668-683
Closed Access | Times Cited: 9
Advancements in nose-to-brain drug targeting for Alzheimer’s disease: a review of nanocarriers and clinical insights
Kumari Komal, Rashmi Ghosh, Debayan Sil, et al.
Inflammopharmacology (2025)
Closed Access | Times Cited: 1
Revolutionizing Parkinson’s treatment: Harnessing the potential of intranasal nanoemulsions for targeted therapy
Gulshan Sharma, Karan Wadhwa, Shobhit Kumar, et al.
Drug Delivery and Translational Research (2025)
Closed Access | Times Cited: 1
Microspheres: Preparation Methods, Advances, Applications, and Challenges in Drug Delivery
Krupali Bhalala, Divyrajsinh Jadeja, Kiran Dudhat
Deleted Journal (2025)
Closed Access | Times Cited: 1
Nanocarriers-mediated nose-to-brain drug delivery: A novel approach for the management of Alzheimer’s disease
Abhishek Sonwani, Anchal Pathak, Keerti Jain
Journal of Drug Delivery Science and Technology (2024) Vol. 98, pp. 105855-105855
Closed Access | Times Cited: 8
Integrative approach of omics and imaging data to discover new insights for understanding brain diseases
Jong Hyuk Yoon, Hagyeong Lee, Dayoung Kwon, et al.
Brain Communications (2024) Vol. 6, Iss. 4
Open Access | Times Cited: 4
Oxytocin lipidation expanding therapeutics for long-term reversal of autistic behaviors in rats
Honglin Li, Ya Chen, Yue Qiu
International Journal of Pharmaceutics (2025), pp. 125299-125299
Closed Access
Nose-to-brain delivery of targeted lipid nanoparticles as two-pronged β-amyloid nanoscavenger for Alzheimer’s disease therapy
Yanyan Xu, X W Ye, Yanfeng Du, et al.
Acta Pharmaceutica Sinica B (2025)
Open Access
Intranasal Drug Delivery: Pathways, Challenges, and Advancements in CNS Targeting
Noura Al‐Hajaj, Reem Khalil, Ghaleb A. Husseini
Journal of Drug Delivery Science and Technology (2025), pp. 106825-106825
Closed Access
The review of nasal drug delivery system: The strategies to enhance the efficiency of intranasal drug delivery by improving drug absorption
Shuhua Wei, Zizhao Zhai, Xi Kong, et al.
International Journal of Pharmaceutics (2025), pp. 125584-125584
Closed Access
Exosome-powered neuropharmaceutics: unlocking the blood-brain barrier for next-gen therapies
Shahab Mehdizadeh, Mobin Mamaghani, Somayyeh Hassanikia, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access
Ceftriaxone-loaded albumin-based nanoparticles incorporated into in situ ionic sensitive nasal gels: Development, characterization, and nasal drug deposition studies
Sandra Aulia Mardikasari, Gábor Katona, Laura Nižić Nodilo, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2025), pp. 114743-114743
Closed Access
Nasal Drug Delivery and Nose-to-Brain Delivery Technology Development Status and Trend Analysis: Based on Questionnaire Survey and Patent Analysis
Yuanyuan Ge, Xingying Xu, Meng Cao, et al.
Pharmaceutics (2024) Vol. 16, Iss. 7, pp. 929-929
Open Access | Times Cited: 3
Recent developments in selective therapeutic targeting of functionalized nanomaterials to neurovascular units in overcoming the gaps in neurovascular therapy
Sakshi Goswami, Н. К. Исаев, Vladimir V. Salmin, et al.
Brain Disorders (2024) Vol. 15, pp. 100162-100162
Open Access | Times Cited: 3
Key Challenges, Influencing Factors, and Future Perspectives of Nanosuspensions in Enhancing Brain Drug Delivery
Wenlu Wang, Chongzhao Yang, Linying Xue, et al.
Current Pharmaceutical Design (2024) Vol. 30, Iss. 32, pp. 2524-2537
Closed Access | Times Cited: 1
Extracellular nanovesicles as neurotherapeutics for central nervous system disorders
Naznin Bhom, Khonzisizwe Somandi, Poornima Ramburrun, et al.
Expert Opinion on Drug Delivery (2024)
Open Access | Times Cited: 1
Development of Thermosensitive Mucoadhesive Gel Based Encapsulated Lipid Microspheres as Nose-to-Brain Rivastigmine Delivery System
Nurafni Annisa Achmad, Rachmatya W. Tuna, Irfan Kurniawan, et al.
Langmuir (2024)
Closed Access | Times Cited: 1
Intranasal Immunotherapy with M2 Macrophage Secretome Ameliorates Language Impairments and Autistic-like Behavior in Children
Е. Ya. Shevela, Tatiana A. Loginova, Alexandr S. Munkuev, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 11, pp. 3079-3079
Open Access
Page 1

Scroll to top